what happens if you overdose on tirzepatide Glucagon-like peptide receptors agonist exposures the rise what can happen if you

2025 FDA shipping data shows that shipments of semaglutide and tirzepatide dropped by 90 and 34 percent, respectively, from June 2024 to June 2025

William Clearfield, D.O., F.A.F.R.M, F.A.A.M.A, D.A.B.M.A

Rubino D., Abrahamsson N., Davies M., et al., Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial, JAMA 325, no

Even if Lilly chases the obesity indication as a second label, the AUD trials are the priority and the Phase 1 obesity program is years behind

Diabetic retinopathy: I would apply the same restrictions as recommended for GLP-1 RAs (see previous At a glance factsheet ) 8 that is, avoid in people with active retinopathy needing ophthalmology review (usually by ensuring that eye screening is up to date)

Product availability at the time of dispensing may vary due to supply chain conditions